<html>
<head>PUBMED IDs for PUS1</head>
<body bgcolor='#C5F0F2'><h1>PUS1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15103716/'>Gene responsible for mitochondrial myopathy and sideroblastic anemia (MSA) maps to chromosome 12q24.33.</a> April 23  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15108122/'>Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA).</a> April 27  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15772074/'>Mitochondrial myopathy and sideroblastic anemia (MLASA): missense mutation in the pseudouridine synthase 1 (PUS1) gene is associated with the loss of tRNA pseudouridylation.</a> March 18  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15971356/'>Mitochondrial myopathy, sideroblastic anemia, and lactic acidosis: an autosomal recessive syndrome in Persian Jews caused by a mutation in the PUS1 gene.</a> June 24  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15977303/'>Towards gene therapy in prosthesis loosening: efficient killing of interface cells by gene-directed enzyme prodrug therapy with nitroreductase and the prodrug CB1954.</a> June 25  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17056637/'>Nonsense mutation in pseudouridylate synthase 1 (PUS1) in two brothers affected by myopathy, lactic acidosis and sideroblastic anaemia (MLASA).</a> October 24  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17374500/'>Pleiotropic effects and compensation mechanisms determine tissue specificity in mitochondrial myopathy and sideroblastic anemia (MLASA).</a> March 22  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19124578/'>A pseudouridine synthase homologue is critical to cellular differentiation in Toxoplasma gondii.</a> June 23  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20598274/'>Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia--MLASA syndrome.</a> July 29  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/23918765/'>A distinct mitochondrial myopathy, lactic acidosis and sideroblastic anemia (MLASA) phenotype associates with YARS2 mutations.</a> March 29  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24003969/'>Pathophysiology and genetic mutations in congenital sideroblastic anemia.</a> April 4  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25037980/'>Mitochondrial myopathy, lactic acidosis, and sideroblastic anemia (MLASA) plus associated with a novel de novo mutation (m.8969G&gt;A) in the mitochondrial encoded ATP6 gene.</a> October 16  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25227147/'>Unusual clinical expression and long survival of a pseudouridylate synthase (PUS1) mutation into adulthood.</a> February 4  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26075521/'>Chemical pulldown reveals dynamic pseudouridylation of the mammalian transcriptome.</a> October 10  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26556812/'>Clinical and molecular study in a long-surviving patient with MLASA syndrome due to novel PUS1 mutations.</a> November 12  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26738999/'>eQTL analysis links inflammatory bowel disease associated 1q21 locus to ECM1 gene.</a> January 12  2016<br></body></html>
